![Anna Schwickart](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Anna Schwickart
Plus aucun poste en cours
Profil
Anna Schwickart is the founder of Rigontec GmbH, which was founded in 2014.
Anciens postes connus de Anna Schwickart
Sociétés | Poste | Fin |
---|---|---|
Rigontec GmbH
![]() Rigontec GmbH Pharmaceuticals: MajorHealth Technology Rigontec GmbH provides RNA-based immunotherapeutics for the treatment of cancer and viral diseases. The firm develops a compound stimulating the immune receptor retinoic acid-inducible gene. The company was founded by Annegret de Baey-Diepolder, Gunther Hartmann, Anna Schwickart, Marcel Renn, Christine Schuberth-Wagner and Veit Hornung in 2014 and is headquartered in Munich, Germany. | Fondateur | - |
Expériences
Fonctions occupées
Sociétés liées
Entreprise privées | 1 |
---|---|
Rigontec GmbH
![]() Rigontec GmbH Pharmaceuticals: MajorHealth Technology Rigontec GmbH provides RNA-based immunotherapeutics for the treatment of cancer and viral diseases. The firm develops a compound stimulating the immune receptor retinoic acid-inducible gene. The company was founded by Annegret de Baey-Diepolder, Gunther Hartmann, Anna Schwickart, Marcel Renn, Christine Schuberth-Wagner and Veit Hornung in 2014 and is headquartered in Munich, Germany. | Health Technology |